NFE2L2 and colorectal carcinoma: This leads to the upregulation of nuclear factor erythroid 2-related factor 2 (NRF2) and thioredoxin 1 (Trx1), which is a regulator of antioxidant defense mechanism, inhibits the migration and survival of CRC cells by inhibiting EMT induction [168].